<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01794026</url>
  </required_header>
  <id_info>
    <org_study_id>DWMRIGASTADENO</org_study_id>
    <nct_id>NCT01794026</nct_id>
  </id_info>
  <brief_title>Diffusion Weighted Magnetic Resonance Imaging for Preoperative Staging in Gastric Adenocarcinoma Patients</brief_title>
  <official_title>Use of Diffusion Weighted Magnetic Resonance Imaging to Stage Gastric Adenocarcinoma Patients Preoperatively</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bezmialem Vakif University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bezmialem Vakif University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preoperative staging for gastric adenocarcinoma is an important procedure to detect advanced&#xD;
      disease stateS for the patients in which the surgery may be unnecessary to perform. Although&#xD;
      there are many imaging techniques for this purpose, sensitivity and specificity of these&#xD;
      techniques still remains to be low.Preoperative detection of peritoneal carcinomatosis and&#xD;
      involvement of lymph nodes beyond D2 may prevent surgical procedures.&#xD;
&#xD;
      Removal of the determined lymph nodes according to the type of the surgery is the accepted&#xD;
      surgical method. However, accurate determination of malignant lymph nodes may prevent&#xD;
      dissection of some groups of the lymph nodes. These findings may cause a new definition of&#xD;
      gastric lymph node dissection.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. proven endoscopic diagnosis of gastric adenocarcinoma&#xD;
&#xD;
        2. for staging purposes, computed tomography for all patients&#xD;
&#xD;
        3. evaluation of benign and malignant lymph nodes according to computed tomography findings&#xD;
           and mapping of the lymph nodes&#xD;
&#xD;
        4. to state precisely resectable patients according to computed tomography and anesthetic&#xD;
           evaluation&#xD;
&#xD;
        5. evaluation of benign and malignant lymph nodes according to diffusion weighted magnetic&#xD;
           resonance imaging findings and mapping of the lymph nodes&#xD;
&#xD;
        6. standard gastrectomy and D2 lymph node dissection&#xD;
&#xD;
        7. mapping of the lymph nodes after taking the specimen out&#xD;
&#xD;
        8. histopathological diagnosis of the lymph nodes and mapping&#xD;
&#xD;
        9. comparison of the results taken from computed tomography, diffusion weighted magnetic&#xD;
           resonance imaging and histopathological analysis&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>efficacy of diffusion weighted magnetic resonance imaging to detect benign and malignant lymph nodes</measure>
    <time_frame>one year</time_frame>
    <description>to compare the radiologic diagnosis of benign and malignant lymph nodes with histopathological diagnosis</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Gastric Adenocarcinoma</condition>
  <arm_group>
    <arm_group_label>diffusion MRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>histopathology of lymph nodes diagnosed by diffusion weighted magnetic resonance imaging</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>diffusion weighted magnetic resonance imaging</intervention_name>
    <description>for diagnostic purposes, diffusion weighted magnetic resonance imaging in all patients</description>
    <arm_group_label>diffusion MRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  gastric adenocarcinoma proven by endoscopic biopsy;&#xD;
&#xD;
          -  application of both computed tomography and diffusion weighted magnetic resonance&#xD;
             imaging;&#xD;
&#xD;
          -  standard gastrectomy and a D2 lymph node dissection;&#xD;
&#xD;
          -  desire to attend the study protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  preoperative neoadjuvant therapy;&#xD;
&#xD;
          -  metastatic disease;&#xD;
&#xD;
          -  undesired reaction to attend the study protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bezmialem Vakif University Faculty of Medicine Dept of General Surgery</name>
      <address>
        <city>Istanbul</city>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <study_first_submitted>February 15, 2013</study_first_submitted>
  <study_first_submitted_qc>February 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 18, 2013</study_first_posted>
  <last_update_submitted>February 28, 2017</last_update_submitted>
  <last_update_submitted_qc>February 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diffusion weighted</keyword>
  <keyword>magnetic resonance imaging</keyword>
  <keyword>surgery</keyword>
  <keyword>histopathology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Body Weight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

